Practical insights for the clinical implementation of the EULAR recommendations for patients with systemic lupus erythematosus
Year: 2025
Type: article
Abstract: OBJECTIVES: The European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of systemic lupus erythematosus (SLE) and lupus nephritis provide important guidance for practitioners on diagnosis, monitoring and treatment. However, practical barriers, such as time constraints, may pose challenges to practitioners when implementing these recommendations in real-world settings. We provide practical, expert-driven advice on how practitioners may effectively and efficiently implement the EULAR recommendations in routine clinical practice. METHODS: Eight international SLE experts convened and contributed opinions and advice for practitioners via an online survey containing 17 open-ended questions on implementation of the EULAR recommendations for early diagnosis, treatment targets and the use of glucocorticoids (GCs), immunosuppressants and biologics. Survey results were compiled and analysed to reach consensus on key advice points for each topic. RESULTS: Expert advice covered four key topics-setting standardised targets to help modify disease course and prevent organ damage; taking action to achieve these targets; monitoring of target achievement through validated clinical tools and frameworks; and optimising the therapeutic strategy to prevent flares and GC-associated toxicities. A total of 13 core expert-driven advice points were developed across these topics, including scenarios for consideration of earlier biological and/or conventional immunosuppressive use, specific risk factors for poorer prognosis to inform treatment decisions and suggestions on GC tapering. CONCLUSIONS: These expert insights could facilitate implementation of the EULAR recommendations for the management of SLE in clinical practice, thereby helping patients achieve treatment targets and prevent and/or delay organ damage progression.
Source: RMD Open
Institutions: Karolinska University Hospital, Örebro University, Karolinska Institutet, National and Kapodistrian University of Athens, University General Hospital Attikon, University of Ferrara, Arcispedale Sant'Anna, Stadtspital Zürich, University Medical Center of the Johannes Gutenberg University Mainz, GlaxoSmithKline (Spain), GlaxoSmithKline (United States), Hospital Universitario de Gran Canaria Doctor Negrín, Humboldt-Universität zu Berlin, German Rheumatism Research Centre, Charité - Universitätsmedizin Berlin, Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Centre d'Immunologie et des Maladies Infectieuses
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,391
OpenAlex ID: W7117794926
